Grace Therapeutics, Inc. (GRCE) Net Income by Year
Grace Therapeutics, Inc. reported a net loss of $7.8M in fiscal year 2026. This represents an increase of 18.6% from the prior fiscal year. The table below carries 8 fiscal years, from 2019 to 2026, and the quarters Grace Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
GRCE Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
GRCE Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Grace Therapeutics, Inc. financials
Frequently Asked Questions
What was Grace Therapeutics, Inc.'s net income in fiscal year 2026?
Grace Therapeutics, Inc. reported a net loss of $7.8M in fiscal year 2026.
How fast is Grace Therapeutics, Inc.'s net income growing?
Grace Therapeutics, Inc. (GRCE) net income rose by 18.6% year over year, from -$9.6M to -$7.8M in fiscal year 2026.
How has Grace Therapeutics, Inc.'s net income changed over the years?
Across the 8 fiscal years this page covers, Grace Therapeutics, Inc. (GRCE) net income went from -$39.4M in fiscal year 2019 to -$7.8M in fiscal year 2026.
What was Grace Therapeutics, Inc.'s net income in the most recent quarter?
Grace Therapeutics, Inc. (GRCE) reported -$15.8M in net income in Q1 2027. This represents a decrease of 369.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Grace Therapeutics, Inc. (GRCE) reported on that line in every period on record.